Search

everythinglearnresearchcommunity

for

Search:↓

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

HIV can cause unusual and severe skin problems that are hard to treat.

Zinc supplements can resolve skin issues caused by zinc deficiency.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.